Sandra Milligan
President en ASPIRA WOMEN'S HEALTH INC. .
Fortuna: 575 421 $ al 31/03/2024
Perfil
Sandra Milligan es directora independiente de Gossamer Bio, Inc. y jefa de investigación y desarrollo de Organon & Co. Forma parte del Consejo de Administración de Gossamer Bio, Inc. La Sra. Milligan trabajó anteriormente como Vicepresidenta de Asuntos Reglamentarios en Genentech, Inc. Se licenció en la Universidad de California, Irvine, se graduó en el Centro de Derecho de la Universidad de Georgetown y se doctoró en la Facultad de Medicina y Salud de la Universidad George Washington.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ORGANON & CO.
0.01% | 04/05/2023 | 28 599 ( 0.01% ) | 537 661 $ | 31/03/2024 |
GOSSAMER BIO, INC.
0.01% | 15/11/2023 | 32 000 ( 0.01% ) | 37 760 $ | 31/03/2024 |
Cargos activos de Sandra Milligan
| Empresas | Cargo | Inicio |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 10/06/2021 |
| ASPIRA WOMEN'S HEALTH INC. | President | 01/04/2024 |
Antiguos cargos conocidos de Sandra Milligan.
| Empresas | Cargo | Fin |
|---|---|---|
| ORGANON & CO. | Chief Tech/Sci/R&D Officer | 01/01/2024 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01/04/2020 |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Director/Board Member | 01/01/2017 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2015 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Formación de Sandra Milligan.
| University of California, Irvine | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
| The United States Army Medical Service Corps |
- Bolsa de valores
- Insiders
- Sandra Milligan
